Recombinant FVIIa

Vox Sanguinis, Supplement

Volumn 87, Issue 2, 2004, Pages

  Hedner, Ulla ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN;

CONFERENCE PAPER; DRUG MECHANISM; DRUG SAFETY; HEMOPHILIA; HEMOSTASIS; PRIORITY JOURNAL;

ANIMALS; CRICETINAE; FACTOR VII; HEMOPHILIA A; HEMOSTASIS; HUMANS; RECOMBINANT PROTEINS;

EID: 4444252072     PISSN: 17416892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Ratnoff OD, Davie EW: The activation of Christmas factor (factor IX) by activated plasma thromboplastin antecedent (activated factor XI). Biochemistry 1962; 1:677-85
2. Macfarlane RG: An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202:498-9
3. Morawitz P: Die chemie der Blutgerinnung. Ergeb Physiol 1905; 4:307-14
4. Waaler BA: Simultaneous contribution to the formation of thrombin by the intrinsic and extrinsic blood clotting systems. Scand J Clin Laboratory Invest 1957; 9:322-30
5. Biggs R, Nossel HL: Tissue extract and the contact reaction of blood coagulation. Thromb Diath Haemorrh 1961; 6:1-14
6. Josso F, Prou-Wartelle O: Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorrh 1965; 17 (Suppl.): 35-44
7. Rapaport SI, Rao LVM: The tissue factor pathway: How it has become a 'prima ballerina'. Thromb Haemost 1995; 74:7-17
8. Nemerson Y: The tissue factor pathway of blood coagulation. Semin Hematol 1992; 29:170-6
9. Repke D, Gemmell CH, Guha A, Turitto VT, Broze GJ Jr, Nemerson Y: Hemophilia as a defect of the tissue factor pathway of blood coagulation: Effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci USA 1990; 87:7623-7
10. Monroe DM, Hoffman M, Roberts HR: Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinol 1996; 7:459-64
11. Monroe DM, Roberts HR, Hoffman M: Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol 1994; 88:364-71
12. Hoffman M, Monroe DM: A cell based model of hemostasis. Thromb Haemost 2001; 85:958-65
13. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG: Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 2002; 99:923-30
14. Hedner U, Kisiel W: Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. J Clin Invest 1983; 71:1836-41
15. Hedner U, Erhardtsen E: Potential role of recombinant factor VIIa as a hemostatic agent. Clin Adv Hemat Onc 2004: in press
16. Niemetz J, Marcus AJ: The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest 1974; 54:1437-43
17. McGill M, Fugman DA, Vittorio N, Darrow C: Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits. J lab Clin Med 1987; 109:127-33
18. Amirkhosravi A, Alexander M, May K, Francis DA, Warnes G, Biggerstaff J, Francis JL: The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996; 75:87-95
19. Giesen PL, Rauch U, Bohrmann G, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y: Blood-borne tissue factor: Another view of thrombosis. Proc Natl Acad Sci USA 1999; 96:2311-5
20. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y: Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96:170-5
21. Himber J, Wohlgensinger C, Roux S, Damico LA, Fallon JT, Kirchhofer D, Nemerson Y, Riederer MA: Inhibition of tissue factor limits the growth of venous thrombus in the rabbit. J Thromb Haemost 2003; 1:889-95
22. Gruber A, Carlson S, Kotzé H, Sarich TC, Marzec U, Hanson SR: Activated factor VII is hemostatic without promoting thrombus propagation. Blood 2003; 102:809a (abstract 2998)
23. Meisel SR, Shechter M, Xu XP, Edgington TS, Cercek B, Shah PK: Platelet-induced expression of tissue factor procoagulant activity in freshly isolated human mononuclear cells: Implications for experimental use. Clin Lab Haem 2003; 25:321-5
24. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B: P-selection induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 1994; 91:8767-71
25. Altieri DC, Bader R, Mannucci PM, Edgington TS: Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition soecificity for fibrinogen. J Cell Biol 1988; 107:1893-1900
26. Bennett JS, Shattil SJ, Power JW, Gartner TK: Interaction of fibrinogen with its platelet receptor: Differential effects of α and γ chain fibrinogen peptides on the glycoprotein IIb and IIIa complex. J Biol Chem 1988; 263:12948-53
27. Falati S, Gross P, Merrill-Skoloff G, Croce K, Furie BC, Furie B: In vivo real time imaging of arterial thrombus formation reveals P-selectin- and PSGL-1-mediated tissue factor accumulation as a mechanism for fibrin clot generation. Blood 2001; 98:823a
28. Furie B, Furie BC, Flaumenhaft R: A journey with platelet P-selectin: The molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001; 86:214-21
29. Müller I, Alex M, Klocke A, Morgenstern E, Kotzsch M, Luther T, Zieseniss S, Preissner K, Engelmann B: Microvesicle and platelet associated tissue factor promote initiation of coagulation. XIX Congr International Soc Thromb Haemost. J Thromb Haemost 2003; 1 (Suppl. 1): Abstract OC007
30. Siddiqui FA, Dessai H, Amirkhosravi A, Siddiqui TF, Meyer T, Amaya M, Francis JL: Platelet microparticles from healthy donors contain tissue factor. Blood 2002; 100 (Abstract 1936)
31. Engelmann B, Luther T, Müller I: Intravascular tissue factor pathway - a model for rapid initiation of coagulation within the blood vessel. Thromb Haemost 2003; 89:3-8
32. Andrė P, Hartwell P, Hrachovinova I, Saffaripour S, Wagner DD: Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000; 97:13835-40
33. Snapp KR, Heitzig CE, Kansas GS: Attachment of the PSGL-1 cytoplasmic domain to the actin cytoskeleton is essential for leukocyte rolling on P-selectin. Blood 2002; 99:4494-502
34. Lupu F, Westmuckett AD, Taylor FB Jr: Cell and tissue-specific expression of tissue factor pathway proteins in a baboon model of lethal E. Coli sepsis. Blood 2002; 100 (Abstract 1933)
35. Camera M, Frigerio M, Marenzi GC, Salvioni A, Biglioli P, Termoli E: Platelet-associated tissue factor expression in patients with unstable coronary artery disease. XIX Congr International Soc Thromb Haemost. J Thromb Haemost 2003; 1 (Suppl. 1): Abstract OC009
36. Zillman A, Luther T, Müller I, Kotzsch M, Spannagl M, Kaule T, Oelschlägel U, Zahler S, Engelmann B: Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Comm 2001; 281:603-9
37. Monroe DM, Hoffman M, Roberts HR: Platelets and thrombin generation. Art Thromb Vasc Biol 2002; 22:1381-9
38. Walsh PN: Roles of factor XI, platelets and tissue factor-initiated blood coagulation. J Thromb Haemost 2003; 1:2081-6
39. Butenas S, Dee JD, Mann G: The function of factor XI in tissue factor-initiated thrombin generation. J Thromb Haemost 2003; 1:2103-11
40. van dem Borne PA, Kr Bouma BN: Feedback activation of factor XI by 1thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995; 86:3035-42
41. He S, Blombäck M, Jacobsson Ekman G, Hedner U: The role of recombinant factor VIIa (rFVIIa) in fibrin structure in the absence of FVIII/FIX. J Thromb Haemost 2003; 1:1215-9
42. Lisman T, Mosnier LO, Lambert T, Mauser-Bunschoten EP, Meijers JCM, Nieuwenhuis HK, de Groot PG: Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A. Blood 2002; 99:175-9
43. Hedner U, Ingerslev J: Clinical use of recombinant FVIIa (rFVIIa). Transfus Sci 1998; 19:163-76
44. Friederich PW, Geerdink MGF, Keller TT, Messelink EJ, Henny GD, Levi M: Novel applications of recombinant factor VIIa: The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy, the PROSE study. Inf Ther Transf 2001; 26:112-3
45. Levi M: Safety of recombinant factor VIIa. J Thromb Haemost 2004; 2:in press